scorecardresearch
Wednesday, March 27, 2024
Support Our Journalism
HomeHealthFirst batch of Covaxin from Bharat Biotech's new plant in Gujarat released

First batch of Covaxin from Bharat Biotech’s new plant in Gujarat released

The central government had earlier this month given approval to Bharat Biotech's Ankleshwar-based plant to produce Covaxin.

Follow Us :
Text Size:

Ankleshwar: The first commercial batch of Covaxin was released on Sunday from the new plant of Bharat Biotech at Ankleshwar in Gujarat’s Bharuch district by Union Health Minister Mansukh Mandaviya.

“Vaccination is the most important thing to strengthen the country’s fight against coronavirus. Released the first commercial batch of #COVAXIN from Bharat Biotech’s plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in the country and will help the vaccine reach every Indian,” Mandaviya tweeted soon after the event.

The government had earlier this month given approval to Bharat Biotech’s Ankleshwar-based manufacturing plant to produce anti-COVID-19 vaccine Covaxin.

In May, Bharat Biotech announced that it planned to produce an additional 200 million doses of Covaxin at its subsidiary’s Ankleshwar-based facility. The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit, Chiron Behring, to add another 200 million doses of Covaxin.

India administered 63.09 crore doses of COVID-19 vaccination in a nationwide drive till Sunday morning, as per the data released by the Union Health Ministry.


Also read: Covid in India may be entering endemic stage, WHO chief scientist Soumya Swaminathan says


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular